Bio-Techne
TECH
575 hedge funds and large institutions have $19.1B invested in Bio-Techne in 2021 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 204 increasing their positions, 204 reducing their positions, and 55 closing their positions.
32% more call options, than puts
Call options by funds: $30.5M | Put options by funds: $23.1M
29% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 55
7% more capital invested
Capital invested by funds: $17.8B → $19.1B (+$1.3B)
2% more funds holding
Funds holding: 566 → 575 (+9)
1.58% more ownership
Funds ownership: 374.79% → 376.37% (+1.6%)
0% more repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 204
6% less funds holding in top 10
Funds holding in top 10: 16 → 15 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$172M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$165M |
| 3 |
State Street
Boston,
Massachusetts
|
+$36.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$34.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$98.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$58.5M |
| 3 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$55.9M |
| 4 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$41.4M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$37.8M |
TECH Hedge Fund Activity: Q4 2021 in Review
575 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2021, worth a combined $19.1B — up 7.3% from $17.8B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new TECH positions and 55 closed out — a net gain of 16 holders — while 204 added to existing stakes and 204 trimmed.
The largest buyer was Marshall Wace, adding an estimated $172M. The largest seller was Wells Fargo, cutting an estimated $98.3M.
- 575 institutional investors held Bio-Techne (TECH) as of Q4 2021, up from 566 in Q3 2021.
- Funds reported $19.1B of Bio-Techne stock for Q4 2021, up 7.3% quarter-over-quarter.
- 71 funds opened new Bio-Techne positions in Q4 2021 and 55 closed out, a net change of +16 holders.
- The largest Bio-Techne buyer in Q4 2021 was Marshall Wace, an estimated $172M added.
- The largest Bio-Techne seller in Q4 2021 was Wells Fargo, an estimated $98.3M sold.
Based on aggregated 13F filings for Q4 2021.